Burns Matteson Capital Management, LLC Bio Rad Laboratories, Inc. Transaction History

Burns Matteson Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Dec 11, 2023	SELL	$412.59 - $563.26 $551,220 - $752,515	-1,336 Closed	0 $0
Q2 2022 Dec 11, 2023	BUY	$463.67 - $597.16 $619,463 - $797,805	1,336 New	1,336 $661 Million
Q3 2021 Dec 11, 2023	SELL	$657.71 - $825.77 $412,384 - $517,757	-627 Closed	0 $0
Q2 2021 Dec 11, 2023	BUY	$576.64 - $649.04 $361,553 - $406,948	627 New	627 $404 Million

489

17.8M

44.9K

79.7K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $6.91B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Burns Matteson Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Burns Matteson Capital Management, LLC with notifications on news.